Register for submacular hemorrhages in age-related macular degeneration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035924

Enrollment

500

Registered

2025-03-10

Start date

2025-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H35.30

Interventions

Group 1: Patients with submacular hemorrhaged due to age-related macular degeneration Examinations, which will be performed at every visit (Day 1, Month 1, Month 3, Month 6, Month 12): - Optical cohe

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with subretinal hemorrhage due to neovascular AMD - Age = 18 years - Ability to give consent - Signed declaration of consent is available

Exclusion criteria

Exclusion criteria: - Patients with subretinal hemorrhage due to other causes, such as retinal macroaneurysm - Lack of consent or refusal to participate - inability to attend regular visits as part of the registry.

Design outcomes

Primary

Measure	Time frame
• Dimensions of hemorrhage regarding size and height as well as best corrected visual acuity with standard deviation, min. and max. • Comparison between patients with or without blood thinning therapy - Evaluation after Day 1, 1 month, 3 months, 6 months , 12 months	—

Secondary

Measure	Time frame
• Number of patients with complications, subcategorized into minor and major complications, assessment complications and time of occurrence • Number of patients with blood-thinning therapy • Differences among different blood-thinning drugs	—

Countries

Germany

Contacts

Public ContactRaffael Liegl

Universitäts-Augenklinik Bonn

raffael.liegl@ukbonn.de+4922828716339

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026